Kuehne+Nagel has announced the expansion of its Cool Corridor network by integrating four additional airfreight lanes specifically designed for pharmaceutical logistics. This development brings the total number of dedicated routes in the network to twelve, significantly bolstering the global capacity for temperature-controlled healthcare shipments.
The Cool Corridor initiative focuses on providing a reliable and compliant environment for transporting sensitive pharmaceutical products. By offering enhanced temperature control throughout the airfreight journey, the network enables shippers to potentially reduce their operational costs through the adoption of lighter, less complex packaging solutions. This also ensures adherence to Good Distribution Practice (GDP) standards, which are critical for maintaining product integrity and safety within the pharmaceutical supply chain.
For freight forwarders and operations managers, this expansion signifies increased options and potentially more competitive pricing for pharma airfreight. The enhanced network reliability and GDP compliance can streamline the shipping process for pharmaceutical clients, reducing risks associated with temperature excursions. The ability to use lighter packaging could also lead to savings in overall shipment weight and volume, impacting freight charges. Forwarders should evaluate these new lanes for their clients' specific origin-destination pairs to leverage the benefits of this expanded network.
The article does not specify the exact new routes or future expansion plans.
